Who Paid My Doc
Rickey Hudson
Adolescent Medicine Memphis, TN Medical Doctor
NPI 1609981752 CMS profile 750908
4299 Elvis Presley Blvd, Ste 3, Memphis, TN 38116
General payments
$269
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Rickey Hudson of Memphis, TN is reported in the CMS Open Payments database as having received $269 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $269 | 1 |
Beside peers
- Rickey Hudson
- Adolescent Medicine median
- Middle half of Adolescent Medicine
- National median
In program year 2025, general payments to Rickey Hudson were reported at $0. Among 40 Adolescent Medicine profiles paid that year, the median was $135 and the middle half received between $78 and $573.
Show as a table
| Year | Rickey Hudson | Adolescent Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $112 | $24–$444 | $163 |
| 2020 | $0 | $80 | $35–$250 | $114 |
| 2021 | $0 | $229 | $55–$448 | $132 |
| 2022 | $0 | $162 | $35–$492 | $149 |
| 2023 | $0 | $182 | $54–$507 | $160 |
| 2024 | $269 | $142 | $59–$362 | $164 |
| 2025 | $0 | $135 | $78–$573 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 68 drugsPart D claims
3,789
Drug cost
$111,586
Branded share of claims
19.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 24 | $22,011 | |
| Eliquis Apixaban | Brand | 22 | $16,718 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 356 | $10,429 | |
| Farxiga Dapagliflozin Propanediol | Brand | 13 | $9,783 | |
| Colchicine | Generic | 78 | $9,510 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 151 | $4,309 | |
| Humalog Mix 75-25 Insulin Lispro Protamin/Lispro | Brand | 12 | $4,131 | |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | Brand | 16 | $3,155 | |
| Fluticasone Propionate | Generic | 126 | $2,132 | |
| Omeprazole | Generic | 128 | $2,024 |
The 10 drugs with the highest cost, of 68 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$12,198
Medicare patients
25
Services billed
239
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 56% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adolescent Medicine in Tennessee
Related records
Adolescent Medicine in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Adolescent Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.